Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
COVID-19: Drug Targets and Potential TreatmentsJournal of Medicinal Chemistry, 2020-11 [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.acs.org/content/acs/en/terms.html ;DOI: 10.1021/acs.jmedchem.0c00606Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial PrescribingClinical infectious diseases, 2020-12, Vol.71 (9), p.2459-2468 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciaa530 ;PMID: 32358954Full text available |
|
3 |
Material Type: Article
|
Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 VariantsNew England Journal of Medicine, 2022-04, Vol.386 (16), p.1579-1580 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2201849 ;PMID: 35294809Digital Resources/Online E-Resources |
|
4 |
Material Type: Article
|
Multiple pathways for SARS-CoV-2 resistance to nirmatrelvirNature (London), 2023-01, Vol.613 (7944), p.558-564 [Peer Reviewed Journal]2022. The Author(s). ;Copyright Nature Publishing Group Jan 19, 2023 ;The Author(s) 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-05514-2 ;PMID: 36351451Full text available |
|
5 |
Material Type: Article
|
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemicCell, 2022-02, Vol.185 (3), p.447-456.e11 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.12.032 ;PMID: 35026151Full text available |
|
6 |
Material Type: Article
|
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control studyBMJ (Online), 2021-05, Vol.373, p.n1088-n1088 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n1088 ;PMID: 33985964Full text available |
|
7 |
Material Type: Article
|
A tale of two antiviral targets - and the COVID-19 drugs that bind themNature reviews. Drug discovery, 2022-01, Vol.21 (1), p.3-5 [Peer Reviewed Journal]Nature 2022. ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/d41573-021-00202-8 ;PMID: 34857884Full text available |
|
8 |
Material Type: Article
|
Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 SubvariantsNew England Journal of Medicine, 2022-08, Vol.387 (5), p.468-470 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2207519 ;PMID: 35857646Digital Resources/Online E-Resources |
|
9 |
Material Type: Article
|
Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2New England Journal of Medicine, 2022-04, Vol.386 (15), p.1475-1477 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2201933 ;PMID: 35263535Digital Resources/Online E-Resources |
|
10 |
Material Type: Article
|
Drug repurposing approach to fight COVID-19Pharmacological reports, 2020-12, Vol.72 (6), p.1479-1508 [Peer Reviewed Journal]Maj Institute of Pharmacology Polish Academy of Sciences 2020 ;ISSN: 1734-1140 ;EISSN: 2299-5684 ;DOI: 10.1007/s43440-020-00155-6 ;PMID: 32889701Full text available |
|
11 |
Material Type: Article
|
Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitorsNature communications, 2021-02, Vol.12 (1), p.743-9, Article 743 [Peer Reviewed Journal]This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-21060-3 ;PMID: 33531496Full text available |
|
12 |
Material Type: Article
|
Inhibitors of SARS-CoV-2 Entry: Current and Future OpportunitiesJournal of Medicinal Chemistry, 2020-11 [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.acs.org/content/acs/en/terms.html ;DOI: 10.1021/acs.jmedchem.0c00502Digital Resources/Online E-Resources |
|
13 |
Material Type: Article
|
Early Remdesivir to Prevent Progression to Severe Covid-19 in OutpatientsNew England Journal of Medicine, 2022-01, Vol.386 (4), p.305-315 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2116846 ;PMID: 34937145Digital Resources/Online E-Resources |
|
14 |
Material Type: Article
|
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicityNature (London), 2022-03, Vol.603 (7902), p.706-714 [Peer Reviewed Journal]2022. The Author(s). ;Copyright Nature Publishing Group Mar 24, 2022 ;The Author(s) 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-04474-x ;PMID: 35104837Full text available |
|
15 |
Material Type: Article
|
Role of favipiravir in the treatment of COVID-19International journal of infectious diseases, 2021-01, Vol.102, p.501-508 [Peer Reviewed Journal]2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved. ;2020 The Authors 2020 ;ISSN: 1201-9712 ;EISSN: 1878-3511 ;DOI: 10.1016/j.ijid.2020.10.069 ;PMID: 33130203Full text available |
|
16 |
Material Type: Article
|
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trialThe Lancet, 2020-12, Vol.396 (10267), p.1979-1993 [Peer Reviewed Journal]2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license ;Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at http://creativecommons.org/licenses/by-nc-nd/4.0 ;2020. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. This work is published under http://creativecommons.org/licenses/by-nc-nd/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license 2020 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32466-1 ;PMID: 33220855Digital Resources/Online E-Resources |
|
17 |
Material Type: Article
|
Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron VariantNew England Journal of Medicine, 2022-03, Vol.386 (10), p.995-998 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2119407 ;PMID: 35081300Digital Resources/Online E-Resources |
|
18 |
Material Type: Article
|
A critical overview of computational approaches employed for COVID-19 drug discoveryChemical Society Reviews, 2021-08, Vol.50 (16), p.9121-9151 [Peer Reviewed Journal]2021. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://pubs.rsc.org/en/Journals/ArticleCollectionLanding?themeId=1eac56a1-4121-43c5-b3ec-3d6f9d9226fb&journalName. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0306-0012 ;EISSN: 1460-4744 ;DOI: 10.1039/D0CS01065KDigital Resources/Online E-Resources |
|
19 |
Material Type: Article
|
Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes: Systematic Review and Meta-analysisChest, 2021-03, Vol.159 (3), p.1019-1040 [Peer Reviewed Journal]Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. ;2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. 2020 American College of Chest Physicians ;ISSN: 0012-3692 ;EISSN: 1931-3543 ;DOI: 10.1016/j.chest.2020.10.054 ;PMID: 33129791Full text available |
|
20 |
Material Type: Article
|
SARS-CoV-2 Variants in Patients with ImmunosuppressionNew England Journal of Medicine, 2021-08, Vol.385 (6), p.562-566 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMsb2104756 ;PMID: 34347959Digital Resources/Online E-Resources |